Company news

Orthofix Medical Inc. (NASDAQ:OFIX) news

Every Orthofix Medical Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Orthofix Medical Inc. stock analysis →

Press releases & updates

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

August 5, 2026

Orthofix to Report Second Quarter 2026 Financial Results

July 15, 2026

Orthofix Medical : Investor Presentation - May 21, 2026

May 21, 2026

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

May 6, 2026

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year...

May 5, 2026

Orthofix to Report First Quarter 2026 Financial Results

April 21, 2026

Orthofix Realigns Spine Leadership to Strengthen Focus and Execution

April 9, 2026

Global Bone Growth Stimulator Market Outlook: U.S. Leads Orthopedic Innovation with Orthofix, Bioventus & Zimmer Biomet

April 3, 2026

Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

February 24, 2026

Fox Factory Announces Strategic Board Refresh

February 9, 2026

Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results

February 3, 2026

Orthofix Reports Third Quarter 2025 Financial Results

November 4, 2025

Orthofix to Participate in Upcoming Investor Conferences

October 15, 2025

Orthofix to Report Third Quarter 2025 Financial Results

October 14, 2025

Orthofix Reports Second Quarter 2025 Financial Results

August 5, 2025

Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference

July 16, 2025

Orthofix to Report Second Quarter 2025 Financial Results

July 15, 2025

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

June 17, 2025

Orthofix Reports First Quarter 2025 Financial Results

May 6, 2025

Orthofix to Report First Quarter 2025 Financial Results

April 15, 2025

Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System

March 19, 2025

Orthofix Announces Appointment of Vickie Capps to Board of Directors

March 12, 2025

Orthofix to Participate in the 37th Annual Roth Conference

March 3, 2025

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

February 25, 2025

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

February 17, 2025

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

January 28, 2025

Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets

November 7, 2024

Orthofix Announces New Term Loan

November 7, 2024

Orthofix to Participate in Stifel 2024 Healthcare Conference

October 21, 2024

Orthofix to Report Third Quarter 2024 Financial Results

October 10, 2024

Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fu...

September 23, 2024

Patrick Fisher Joins Orthofix as President of Global Orthopedics Business

August 15, 2024

Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance

August 6, 2024

Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference

July 17, 2024

Orthofix Names Stephanie Walsh Chief Human Resources Officer

July 16, 2024

Orthofix to Report Second Quarter 2024 Financial Results

July 9, 2024

Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System

July 9, 2024

Michael Finegan Named Chair of the Orthofix Board of Directors

June 24, 2024

Aviva McPherron Joins Orthofix as President of Global Operations and Quality

June 18, 2024

Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine

June 11, 2024

Orthofix Names Max Reinhardt President of Global Spine Business

May 23, 2024

Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program

May 16, 2024

Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail

May 9, 2024

Orthofix Reports First Quarter 2024 Results

May 7, 2024

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

April 23, 2024

Orthofix Names Andres Cedron as New Chief Legal Officer

April 16, 2024

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

March 18, 2024

Orthofix Reports Fourth Quarter and Full Year 2023 Results

March 5, 2024

Orthofix Announces New President for Bone Growth Therapies Business

February 29, 2024

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

February 21, 2024

Older →